Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -122,932 | -85,513 | -50,583 | -30,597 | -97,941 |
| Depreciation Amortization | 7,602 | 5,719 | 3,821 | 1,924 | 9,361 |
| Income taxes - deferred | N/A | 0 | N/A | 15 | N/A |
| Accounts receivable | 155 | 3 | 154 | 160 | 397 |
| Other Working Capital | -4,224 | 5 | -2,402 | -77 | 4,507 |
| Other Operating Activity | 22,191 | 6,981 | 4,703 | 2,426 | 16,537 |
| Operating Cash Flow | $-97,208 | $-72,805 | $-44,307 | $-26,149 | $-67,139 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 0 | 0 | 0 | 35,840 |
| PPE Investments | -102 | -88 | -24 | N/A | -267 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,951 |
| Investing Cash Flow | $-102 | $-88 | $-24 | $0 | $37,524 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,012 | 58,866 | 39,395 | 10,361 | 29,281 |
| Other Financing Activity | -3,263 | -2,914 | -2,647 | -2,227 | -904 |
| Financing Cash Flow | $70,749 | $55,952 | $36,748 | $8,134 | $28,377 |
| Exchange Rate Effect | 4,091 | 4,051 | 4,009 | 1,277 | -2,048 |
| Beginning Cash Position | 43,418 | 43,418 | 43,418 | 43,418 | 46,704 |
| End Cash Position | 20,948 | 30,528 | 39,844 | 26,680 | 43,418 |
| Net Cash Flow | $-22,470 | $-12,890 | $-3,574 | $-16,738 | $-3,286 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97,208 | -72,805 | -44,307 | -26,149 | -67,139 |
| Capital Expenditure | -102 | -88 | -24 | N/A | -267 |
| Free Cash Flow | -97,310 | -72,893 | -44,331 | -26,149 | -67,406 |